There are no differences in the outcome of coronary perforations occurring during bivalirudin anticoagulation compared to those occurring during heparin anticoagulation
Background When bivalirudin (BIV) is used as an intraprocedural anticoagulant for PCI in lieu of heparin (HEP), the risk of post-PCI bleeding appears to be smaller. This benefit may be…